Traditionally, drug discovery has focused on small compounds, but peptidic partners are rapidly receiving traction. This new strategy embraces combining short amino acid chains with other biological methods to tackle challenging illness targets. By leveraging the distinctive properties of peptides – such as significant specificity and bioavailab… Read More